(New York, NY) – October 9, 2015 – AiCure, a leading artificial intelligence company in healthcare, has been invited to lead a panel discussion at this year’s CNS Summit: Shaping the Future of Drug Development. Adam Hanina, CEO, will be one of several thought leaders participating and driving the discussion around the future development of clinical trials. The initiative, “Clinical Trials of the Future”, brings together experts in clinical trials, technology, and other relevant disciplines to shape the future of how clinical trials are conducted.
-
Share
-
Recent Press
-
Jul 21, 2026
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Nov 28, 2024
Clinical Research, Inequality and the Future of Women’s Health
-
Jul 21, 2026